Creative Planning’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Sell
70,241
-3,497
-5% -$18.2K ﹤0.01% 3386
2025
Q4
$453K Sell
73,738
-3,979
-5% -$28.9K ﹤0.01% 2925
2025
Q3
$562K Buy
77,717
+43,794
+129% +$260K ﹤0.01% 2610
2025
Q2
$180K Buy
33,923
+9,804
+41% +$57.9K ﹤0.01% 3261
2025
Q1
$214K Buy
24,119
+24,050
+34,855% +$289K ﹤0.01% 3009
2024
Q4
$946 Sell
69
-9,880
-99% -$182K ﹤0.01% 3526
2024
Q3
$273K Buy
9,949
+892
+10% +$24.1K ﹤0.01% 2599
2024
Q2
$222K Buy
+9,057
New +$199K ﹤0.01% 2606
2020
Q1
Sell
-8,951
Closed -$244K 2017
2019
Q4
$244K Buy
8,951
+700
+8% +$19.3K ﹤0.01% 1525
2019
Q3
$236K Buy
+8,251
New +$240K ﹤0.01% 1501
2019
Q2
Sell
-7,500
Closed -$249K 2082
2019
Q1
$249K Sell
7,500
-433
-5% -$13.2K ﹤0.01% 1444
2018
Q4
$231K Buy
7,933
+2,150
+37% +$77.3K ﹤0.01% 1392
2018
Q3
$266K Buy
+5,783
New +$257K ﹤0.01% 1478
2018
Q1
Sell
-6,894
Closed -$237K 2086
2017
Q4
$237K Sell
6,894
-389
-5% -$13.1K ﹤0.01% 1492
2017
Q3
$263K Buy
7,283
+1,083
+17% +$30.9K ﹤0.01% 1417
2017
Q2
$160K Sell
6,200
-171
-3% -$3.63K ﹤0.01% 1653
2017
Q1
$122K Buy
6,371
+671
+12% +$11.9K ﹤0.01% 1830
2016
Q4
$95K Hold
5,700
﹤0.01% 1908
2016
Q3
$117K Hold
5,700
﹤0.01% 1742
2016
Q2
$174K Hold
5,700
﹤0.01% 1321
2016
Q1
$213K Sell
5,700
-200
-3% -$7.54K ﹤0.01% 1176
2015
Q4
$255K Sell
5,900
-100
-2% -$4.22K ﹤0.01% 1069
2015
Q3
$225K Buy
+6,000
New +$213K ﹤0.01% 1129
2015
Q2
Sell
-6,250
Closed -$221K 2321
2015
Q1
$221K Sell
6,250
-2,440
-28% -$87.3K ﹤0.01% 1137
2014
Q4
$296K Buy
8,690
+2,871
+49% +$102K ﹤0.01% 942
2014
Q3
$224K Sell
5,819
-2,321
-29% -$86.6K ﹤0.01% 997
2014
Q2
$317K Sell
8,140
-100
-1% -$3.72K ﹤0.01% 814
2014
Q1
$282K Buy
8,240
+3,040
+58% +$94.2K ﹤0.01% 848
2013
Q4
$109K Hold
5,200
﹤0.01% 1152
2013
Q3
$122K Sell
5,200
-280
-5% -$7.96K ﹤0.01% 994
2013
Q2
$147K Buy
+5,480
New +$159K ﹤0.01% 782

Other funds holding MYGN